Anastasis Biotec
Biotechnology
London, England 121 followers
We are developing a novel, effective and proprietary cancer treatment
About us
Anastasis’ technology relates to a novel treatment applicable to many cancers. These cancers depend on rogue cells multiplying uncontrollably caused by DNA abnormalities (mutations) in important pathways involved in the generation of cancer and cancer stem cells. When there are mutations in these pathways, cancer cells and cancer stem cells, run rogue, multiply and spread uncontrollably.
- Website
-
http://anastasisbiotec.com
External link for Anastasis Biotec
- Industry
- Biotechnology
- Company size
- 2-10 employees
- Headquarters
- London, England
- Type
- Public Company
- Specialties
- Cancer therapy, Biotechnology, and Antibody therapy
Locations
-
Primary
Get directions
56 Haverstock Hill
London, England NW3 2BH, GB
Employees at Anastasis Biotec
-
Monica Hart, MBA, CMktr/FCIM, MA
Passionately curious marketing (growth, product, content) partnership, business development & strategy expert | helps disruptor SMEs see forests &…
-
Raymond Moellering
Professor at University of Chicago, Biotech Entrepreneur
-
Agamemnon Epenetos
Chairman and CEO at Anastasis Biotec Ltd